Zobrazeno 1 - 10
of 58
pro vyhledávání: '"F. A. Nicolini"'
Autor:
C. Kockerols, S. Dulucq, S. Bernardi, M. Farina, I. Civettini, G. Colafigli, S. Mori, P. Valk, F.-X. Mahon, C. Gambacorti-Passerini, F.-E. Nicolini, M. Breccia, D. Russo, P. E. Westerweel
Publikováno v:
HemaSphere, Vol 6, Pp 58-59 (2022)
Externí odkaz:
https://doaj.org/article/a645ba6302e34e1bbb1190720692d775
Autor:
S. Saußele, N. Evans, F. E. Nicolini, E. Chelysheva, D. Réa, F. Castagnetti, S. Claudiani, R. Rodrigues, C. Kok, T. Hughes
Publikováno v:
HemaSphere, Vol 6, Pp 596-597 (2022)
Externí odkaz:
https://doaj.org/article/5302f3c030954a92a7c7e6e8a118c128
Autor:
F. E. Nicolini, G. Etienne, F. Huguet, M. Gu, C. Bouvier, A. Yocolly, R. Favier, M. Trancart, L. Huynh
Publikováno v:
HemaSphere, Vol 6, Pp 600-601 (2022)
Externí odkaz:
https://doaj.org/article/c8beb5f5421e492780c78facaa5aedd1
Autor:
Francois-Xavier Mahon, Martine Gardembas, Agnès Guerci-Bresler, Stéphane Giraudier, Gabriel Etienne, Françoise Huguet, Laurence Legros, Bruno Varet, F. E. Nicolini, Stephane Morisset, Philippe Rousselot, Jean-Christophe Ianotto, Thomas Pagliardini, Irit Touitou, Delphine Rea, Martine Escoffre, Marie-Pierre Noel
Publikováno v:
Cancer. 123:4403-4410
BACKGROUND Several studies have demonstrated that approximately one-half of patients with chronic myeloid leukemia (CML) who receive treatment with tyrosine kinase inhibitors (TKIs) and achieve and maintain a deep molecular response (DMR) are able to
Autor:
A. Mojallal, C. Auxenfans, Hélène Labussière, Laure Lebras, F. Braye, Sophie Ducastelle-Lepretre, Marie-Cécile Michallet, Valérie Dubois, O. Damour, Roberto Crocchiolo, F-E Nicolini, M. Sobh
Publikováno v:
Bone Marrow Transplantation. 52:1060-1062
Autor:
M.M. Trawinska, B. Moiraghi, D.-W. Kim, K. Meliktesyan, P. Ganeva, E. Polushkina, M. Yassin, D. Rea, F. E. Nicolini, K. Kazakbaeva, I. Dyagil, Hana Klamova, S. Saliev, R. Shmakov, A. Turkina, E. Chelysheva, K. Kotlyarchuk, M.J. Mauro, P. Rousselot, E Abruzzese, G. Mikhailov, M. Malagola, S. Osorio, J. Chabaeva, A. Romano, S. Kulikov, D. Cangemi, C. Pavlovsky
Publikováno v:
HemaSphere. 3:395-396
Autor:
Gabriel Etienne, L. Legros, Delphine Rea, Agnès Guerci-Bresler, F.-E. Nicolini, V. Coiteux, F. Huguet, P. Rousselot
Publikováno v:
HemaSphere. 3:874-875
Autor:
P Lagadec, Estelle Duprez, Zouhour Neffati, Els Verhoeyen, Véronique Maguer-Satta, Véronique Imbert, J F Peyron, Chun Peng, L Mourgues, Didier Mary, Laurence Legros, F-E Nicolini, Pascal Colosetti, Marielle Nebout, Nathalie Rochet
Publikováno v:
Leukemia. 29:1993-2002
The BMI1 polycomb protein regulates self-renewal, proliferation and survival of cancer-initiating cells essentially through epigenetic repression of the CDKN2A tumor suppressor locus. We demonstrate here for the first time that BMI1 also prevents aut
Autor:
Wilhelm Haverkamp, Giovanni Rosti, H Labussière, Ruhdja Lindhorst, Theo-D. Kim, Bernd Dörken, P. le Coutre, Hervé Dombret, Francis J. Giles, Peggy Grille, Tristan Mirault, Michaela Schwarz, Delphine Rea, F. E. Nicolini, Luciano Levato, Ivo Buschmann
Publikováno v:
Leukemia. 27:1316-1321
Several retrospective studies have described the clinical manifestation of peripheral artery occlusive disease (PAOD) in patients receiving nilotinib. We thus prospectively screened for PAOD in patients with chronic phase chronic myeloid leukemia (CP
Autor:
A. Conrad, M. Le Maréchal, D. Dupont, S. Ducastelle-Leprêtre, M. Balsat, H. Labussière-Wallet, F. Barraco, F.-E. Nicolini, X. Thomas, L. Gilis, C. Chidiac, T. Ferry, F. Wallet, M. Rabodonirina, G. Salles, M. Michallet, F. Ader, E. Bachy, N. Benech, A.-L. Bienvenu, G. Billaud, F. Biron, A. Boibieux, O. Dumitrescu, V. Escuret, G. Fossard, E. Frobert, S. Goutelle, A. Grateau, Y. Guillermin, M. Heiblig, L. Lebras, B. Lina, G. Lina, P. Miailhes, A.-S. Michallet, M.-C. Michallet, G. Monneret, F. Morfin-Sherpa, T. Perpoint, M. Peyrouse de Montclos, S. Picot, F. Poitevin-Later, A. Quintela, S. Roux, J. Saison, C. Sarkozy, A. Sénéchal, M. Sobh, F. Valour, M. Wallon, E. Wattel
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2016, 22 (7), pp.636-641. ⟨10.1016/j.cmi.2016.04.025⟩
Clinical Microbiology and Infection, 2016, 22 (7), pp.636-641. ⟨10.1016/j.cmi.2016.04.025⟩
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2016, 22 (7), pp.636-641. ⟨10.1016/j.cmi.2016.04.025⟩
Clinical Microbiology and Infection, 2016, 22 (7), pp.636-641. ⟨10.1016/j.cmi.2016.04.025⟩
International audience; Toxoplasmosis (TXP) is a life-threatening complication of allogeneic haematopoietic stem cell transplantation (AHSCT). Little is known about the risk factors and there is no consensus on prophylactic measures. To investigate t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76cb089984ee2423eb753d63b8ecb7a5
https://hal.archives-ouvertes.fr/hal-01792623
https://hal.archives-ouvertes.fr/hal-01792623